discoveri
new
diverg
virus
use
metagenom
highthroughput
sequenc
becom
commonplac
prepar
sampl
known
effect
represent
viru
sequenc
within
metagenom
dataset
yet
compar
littl
attent
given
physic
enrich
techniqu
often
appli
sampl
increas
number
viral
sequenc
therefor
enhanc
probabl
detect
except
viru
ecolog
studi
pauciti
inform
avail
research
type
sampl
prepar
requir
viral
metagenom
studi
seek
identifi
aetiolog
viru
anim
human
diagnost
sampl
review
publish
viru
discoveri
studi
reveal
commonli
use
enrich
method
usual
quick
simpl
implement
name
lowspe
centrifug
filtrat
nucleasetreat
combin
routin
use
often
without
justif
appli
simpl
wellcharacteris
artifici
sampl
compos
bacteri
human
cell
well
dna
adenoviru
rna
virus
influenza
human
enteroviru
either
nonenvelop
capsid
envelop
virus
effect
enrich
method
assess
quantit
realtim
pcr
metagenom
analysi
incorpor
amplif
step
reduct
absolut
quantiti
bacteria
human
cell
observ
method
determin
qpcr
rel
abund
viral
sequenc
metagenom
dataset
remain
larg
unchang
method
centrifug
filtrat
nucleasetreat
show
greatest
increas
proport
viral
sequenc
studi
provid
start
point
select
purif
method
futur
viru
discoveri
studi
highlight
need
data
valid
effect
enrich
method
differ
sampl
type
amplif
bioinformat
approach
sequenc
platform
studi
also
highlight
potenti
risk
may
attend
select
viru
enrich
method
without
consider
sampl
type
investig
sinc
prolifer
highthroughput
sequenc
technolog
search
virus
enter
new
era
lipkin
lipkin
technolog
capabl
produc
million
sequenc
read
without
priori
knowledg
sampl
sequenc
data
gener
sampl
compar
known
sequenc
databas
order
identifi
virus
previous
viru
metagenom
accomplish
clone
sangerbas
sequenc
randomli
amplifi
nucleic
acid
breitbart
et
al
djikeng
et
al
despit
small
amount
sequenc
data
produc
still
possibl
detect
virus
due
either
high
concentr
process
prior
enrich
appli
remov
host
cell
exogen
nucleic
acid
rel
abund
viru
viral
nucleic
acid
sampl
compar
organ
bacteria
host
cell
genom
critic
factor
discoveri
virus
use
metagenom
higher
proport
viral
sequenc
increas
probabl
viral
sequenc
repres
metagenom
dataset
larger
contig
assembl
increas
likelihood
match
databas
shown
without
type
physic
enrich
method
virus
may
present
high
enough
concentr
detect
dali
et
al
problem
somewhat
overcom
highthroughput
sequenc
technolog
advanc
read
length
sequenc
depth
nevertheless
gain
sensit
still
possibl
applic
physic
enrich
process
virus
may
also
avoid
cost
gener
analys
addit
data
field
viral
ecolog
alreadi
signific
advanc
valid
physic
enrich
method
virus
duhaim
sullivan
john
et
al
method
use
concentr
purifi
virus
seawat
viru
discoveri
metagenom
hurwitz
et
al
howev
methodolog
studi
appli
evalu
effici
viral
enrich
method
metagenom
seek
diagnos
anim
human
diseas
studi
human
liver
tissu
compar
enrich
techniqu
freezethaw
centrifug
nucleasetreat
detect
hepat
c
viru
use
roch
illumina
highthroughput
sequenc
platform
dali
et
al
abund
viral
sequenc
treatment
group
compar
result
obtain
quantit
realtim
pcr
detect
transcript
effect
treatment
method
viral
genom
coverag
also
determin
studi
show
physic
enrich
method
increas
sensit
detect
virus
metagenom
new
research
look
perform
work
human
anim
sampl
purpos
detect
diagnos
new
unexpect
virus
difficult
ascertain
viru
enrich
method
may
applic
given
sampl
type
method
describ
viral
ecolog
studi
unlik
applic
review
undertaken
publish
metagenom
studi
sought
describ
virus
present
human
anim
sampl
exclud
viru
ecolog
studi
provid
detail
enrich
method
use
tabl
studi
incorpor
use
lowspe
centrifug
andor
filtrat
remov
host
cell
microorgan
final
nucleasetreat
step
dnase
rnase
destroy
exogen
nucleic
acid
thought
affect
nucleic
acid
protect
viral
capsid
envelop
ultracentrifug
also
featur
common
method
concentr
virus
sampl
applic
viru
discoveri
method
use
metagenom
consid
routin
use
diagnost
refer
laboratori
aid
diagnosi
human
svraka
et
al
anim
diseas
belak
et
al
applic
techniqu
clinic
set
requir
viru
enrich
method
simpl
perform
fast
robust
effect
standardis
requir
signific
capit
expenditur
note
vast
major
publish
studi
tabl
appli
simpl
enrich
techniqu
without
priori
justif
select
techniqu
studi
sought
examin
rapid
simpl
enrich
techniqu
virus
appear
routin
use
literatur
diagnos
anim
human
diseas
effect
metagenom
data
studi
achiev
examin
effect
enrich
method
rel
abund
virus
metagenom
dataset
deriv
simpl
wellcharacteris
artifici
sampl
human
enteroviru
cultur
human
rhabdomyosarcoma
cell
line
hank
mem
life
technolog
carlsbad
ca
usa
supplement
foetal
bovin
serum
thermofish
scientif
waltham
usa
human
adenoviru
also
cultur
human
rhabdomyosarcoma
cell
line
influenza
cultur
cell
canin
rmix
diagnost
hybrid
athen
oh
usa
viru
cultur
compos
cell
cultur
supernat
monolay
present
freezethaw
escherichia
coli
cultur
brain
heart
infus
broth
bhi
incub
c
overnight
human
cell
cultur
dmem
life
technolog
carlsbad
ca
usa
supplement
foetal
bovin
serum
thermofish
scientif
waltham
usa
artifici
sampl
formul
consist
known
amount
e
coli
human
epitheli
lung
carcinoma
cell
atcc
human
enteroviru
human
adenoviru
influenza
aliquot
final
dilut
subject
three
freezethaw
cycl
frozen
store
c
base
upon
review
enrich
method
present
tabl
five
combin
three
simpl
method
enrich
select
perform
ml
aliquot
artifici
sampl
follow
lowspe
centrifug
microfug
g
min
c
steril
syring
filtrat
nucleas
treatment
use
u
l
turbo
dnase
life
technolog
carlsbad
ca
usa
u
l
rnase
one
promega
fitchburg
wi
usa
dnase
buffer
life
technolog
carlsbad
ca
usa
incub
c
min
combin
method
centrifug
follow
filtrat
centrifug
filtrat
nucleasetreat
independ
duplic
treatment
perform
use
subsequ
experi
extract
rna
achiev
use
iprep
purelink
viru
kit
life
technolog
carlsbad
ca
usa
l
artifici
sampl
extract
elut
l
molecularbiolog
grade
water
realtim
quantit
pcr
assay
qpcr
perform
stratagen
realtim
pcr
system
agil
technolog
santa
clara
ca
usa
qpcr
extract
rna
use
quantifi
human
cell
influenza
adenoviru
e
coli
enteroviru
present
artifici
sampl
human
rnase
p
rnp
gene
use
target
detect
human
cellular
rna
nucleoprotein
gene
target
use
detect
influenza
rna
assay
perform
use
agpath
one
step
rtpcr
kit
reagent
life
technolog
carlsbad
ca
usa
primer
probe
assay
previous
describ
l
reaction
contain
l
nucleic
acid
l
rtpcr
buffer
l
rtpcr
enzym
mix
probe
primer
follow
initi
min
revers
transcript
step
c
min
denatur
step
c
cycl
procedur
denatur
c
anneal
extens
c
cycl
use
adenoviru
dna
detect
use
previous
publish
assay
brittainlong
et
al
agpath
one
step
rtpcr
kit
life
technolog
carlsbad
ca
usa
l
reaction
contain
l
dna
l
rtpcr
buffer
l
rtpcr
enzym
mix
probe
primer
initi
min
revers
transcript
step
c
min
denatur
tabl
viru
enrich
process
prior
sequenc
metagenom
studi
human
anim
sampl
author
year
journal
aim
studi
sampl
step
step
step
step
step
step
step
step
step
step
step
step
step
step
step
c
cycl
procedur
denatur
c
anneal
extens
c
min
cycl
use
enteroviru
rna
detect
use
previous
describ
assay
oberst
et
al
step
system
life
technolog
carlsbad
ca
usa
l
reaction
contain
l
rna
l
invitrogen
reaction
mix
l
mgso
l
superscript
iii
rtplatinum
taq
mix
probe
primer
follow
initi
min
revers
transcript
step
c
min
denatur
step
c
cycl
procedur
denatur
c
anneal
c
extens
c
cycl
use
e
coli
onestep
assay
perform
use
lightcycl
probe
mastermix
roch
indianapoli
usa
previous
describ
paton
paton
thoma
et
al
l
reaction
contain
l
dna
l
lightcycl
probe
master
probe
primer
follow
activ
step
c
min
cycl
procedur
denatur
c
anneal
c
extens
c
cycl
use
everi
assay
includ
neg
posit
control
rnasefre
reagent
handl
procedur
realtim
pcr
assay
made
quantit
includ
dilut
seri
plasmid
known
copi
number
contain
concaten
primerprobeprim
target
sequenc
five
assay
dna
copurifi
rna
nucleic
acid
extract
method
thu
dna
remov
use
ambion
dnafre
life
technolog
carlsbad
ca
usa
l
rna
revers
transcrib
cdna
use
firststrand
cdna
synthesi
kit
prime
random
hexam
per
manufactur
instruct
life
technolog
carlsbad
ca
usa
includ
recommend
rnase
h
digest
minimum
g
amount
dna
requir
input
illumina
truseq
dna
librari
prepar
protocol
achiev
amplif
cdna
achiev
use
whole
transcriptom
amplif
kit
qiagen
valencia
ca
usa
describ
previous
berthet
et
al
cheval
et
al
briefli
revers
transcript
step
requir
kit
utilis
ligat
amplif
step
follow
per
manufactur
instruct
except
ligat
reaction
termin
heat
c
min
amplif
step
perform
h
follow
termin
reaction
c
min
sampl
g
dna
produc
sequenc
illumina
miseq
instrument
new
zealand
genom
limit
massey
genom
servic
massey
univers
palmerston
north
new
zealand
use
illumina
truseq
dna
librari
prepar
illumina
san
diego
ca
usa
wateronli
neg
control
fail
amplifi
dna
illumina
miseq
sequenc
data
consist
bp
pairedend
read
qualiti
check
redundantread
collaps
perform
sequenc
read
compar
ncbi
nonredund
nucleotid
databas
download
ncbi
ftp
confid
interv
grey
line
repres
copi
number
target
gene
enrich
method
appli
site
februari
use
blastn
blast
e
valu
use
cutoff
threshold
valu
signific
hit
blastn
output
file
import
pars
megan
huson
et
al
taxonom
assign
abund
nucleic
acid
model
organ
artifici
sampl
human
cell
bacteria
influenza
adenoviru
enteroviru
determin
use
quantit
realtim
pcr
effect
differ
enrich
method
target
gene
copi
number
assess
fig
gener
enrich
method
decreas
quantiti
everi
model
organ
compar
treatment
human
rna
remov
limit
extent
method
treatment
nucleaseonli
treatment
effect
result
reduct
copi
number
similarli
bacteri
nucleic
acid
remov
enrich
method
nucleaseonli
treatment
effect
three
virus
use
experi
repres
dna
viru
adenoviru
two
rna
virus
one
envelop
influenza
nonenvelop
enteroviru
subsequ
metagenom
analysi
target
detect
rna
virus
dna
viru
includ
assess
potenti
detect
dna
virus
use
methodolog
viru
also
repres
differ
level
concentr
high
concentr
copi
enteroviru
moder
concentr
adenoviru
copi
low
concentr
influenza
copi
virus
show
decreas
copi
number
enrich
method
appli
decreas
consist
across
enrich
method
show
greater
reduct
copi
number
except
method
appli
enteroviru
viru
copi
number
reduc
rna
extract
use
qpcr
also
use
metagenom
experi
fig
tabl
first
replic
sampl
treatment
index
run
one
illumina
miseq
run
produc
sequenc
read
bp
length
second
replic
set
index
run
independ
illumina
miseq
run
produc
sequenc
read
bp
length
submiss
blastn
sequenc
read
given
taxonom
assign
use
megan
five
model
organ
repres
untreat
sampl
fig
tabl
simplic
data
represent
famili
level
enterobacteriacea
chosen
repres
ecoli
organ
sampl
abund
taxa
identifi
account
total
sequenc
read
tabl
kingdom
level
metazoa
chosen
repres
human
cell
within
untreat
sampl
account
total
read
read
tabl
decis
use
metazoa
enterobacteriacea
made
facilit
simpl
represent
data
arbitrari
aim
experi
compar
variat
proport
bacteria
human
cell
virus
enrich
method
virus
present
untreat
sampl
follow
proport
enteroviru
read
adenoviru
read
influenza
viru
read
interest
dna
viru
adenoviru
identifi
dataset
given
method
target
rna
virus
combin
total
number
sequenc
read
two
independ
physic
replic
also
run
differ
illumina
miseq
flowcel
figur
repres
collaps
sequenc
data
therefor
redund
read
repres
b
serial
applic
treatment
method
method
consist
centrifug
filtrat
method
consist
centrifug
filtrat
nucleasetreat
assign
aforement
taxa
account
either
hit
blast
search
clear
taxonom
assign
blast
search
due
stringenc
paramet
requir
megan
taxonom
assign
low
complex
sequenc
assign
taxonom
level
captur
enterobacteriacea
metazoa
virus
enrich
techniqu
greatli
chang
rel
abund
enterobacteriacea
best
reduct
number
read
assign
taxon
appli
treatment
increas
proport
metazoa
sequenc
filtrat
appli
increas
nucleasetreat
show
greatest
effect
reduc
metazoan
sequenc
reduct
virus
treatment
treatment
show
signific
increas
proport
viral
sequenc
influenza
enteroviru
proport
adenoviru
hit
appear
unaffect
enrich
method
fig
studi
compar
effect
five
differ
viral
enrich
method
abil
detect
virus
metagenom
approach
enrich
techniqu
deliber
chosen
commonli
referenc
previou
metagenom
studi
seek
identifi
new
rare
virus
tabl
enrich
method
often
select
without
prior
justif
effect
enrich
techniqu
examin
applic
highli
specif
artifici
sampl
studi
provid
full
valid
enrich
method
highlight
possibl
risk
enrich
method
select
base
sole
upon
method
publish
other
without
consider
sampl
examin
valid
enrich
techniqu
field
viru
ecolog
well
develop
duhaim
sullivan
john
et
al
pauciti
data
valid
enrich
method
appli
detect
virus
anim
human
sampl
purpos
diagnosi
present
studi
artifici
sampl
compos
repres
type
organ
could
possibl
observ
clinic
sampl
ie
rectal
swab
taken
human
patient
cours
artifici
sampl
unlik
similar
characterist
complex
biolog
sampl
human
anim
bacteria
often
abund
organ
de
novo
metagenom
dataset
host
sequenc
also
often
present
end
ecoli
human
cell
line
chosen
well
two
rna
virus
influenza
viru
enteroviru
dna
viru
adenoviru
dna
viru
includ
assess
potenti
detect
use
rna
viru
target
approach
mani
viru
discoveri
project
creat
two
workflow
independ
target
dna
rna
virus
differ
amount
viru
place
artifici
sampl
repres
vari
concentr
artifici
sampl
repres
start
point
evalu
simpl
rapid
viral
enrich
method
use
viru
metagenom
studi
seek
detect
viru
caus
diseas
human
anim
present
littl
guidanc
research
seek
work
area
publish
studi
often
select
simpl
enrich
techniqu
justif
inclus
method
gener
observ
choic
enrich
method
low
speed
centrifug
syringebas
filtrat
nucleas
treatment
dnase
rnase
combin
method
substanti
increas
rel
abund
virus
metagenom
dataset
except
select
case
despit
reduct
quantiti
copi
number
bacteri
human
rna
gene
target
shown
qpcr
data
translat
substanti
increas
rel
abund
viral
sequenc
metagenom
data
qpcr
method
detect
absolut
quantiti
genom
target
present
wherea
metagenom
data
proport
rel
abund
even
though
larg
gain
made
reduc
bacteria
human
nucleic
acid
proport
viral
sequenc
metagenom
dataset
still
remain
rel
low
ie
gener
less
except
enrich
method
appli
nevertheless
individu
enrich
method
effect
rel
abund
model
organ
represent
metagenom
data
nucleas
treatment
alon
success
reduc
proport
human
metazoa
sequenc
hypothesis
initi
freezethaw
process
artifici
sampl
lyse
human
cell
thu
liber
human
genom
exogen
nucleic
acid
suscept
digest
nucleas
protect
bacteri
viral
genom
protect
membran
capsid
resist
freezethaw
action
treatment
particularli
effect
increas
abund
influenza
enteroviru
absolut
concentr
measur
realtim
pcr
also
rel
abund
measur
metagenom
data
find
support
use
procedur
viru
enrich
similar
procedur
previous
employ
publish
viru
metagenom
studi
tabl
regard
sensit
without
enrich
method
copi
influenza
viru
genom
detect
use
metagenom
approach
sequenc
read
tabl
detect
dna
genom
adenoviru
present
copi
sequenc
read
tabl
also
possibl
experi
target
discoveri
rna
virus
includ
dna
viru
adenoviru
determin
rna
viru
detect
method
could
also
codetect
dna
virus
given
start
materi
use
experi
rna
possibl
surmis
adenoviru
mrna
express
infect
detect
howev
may
correct
explan
dnase
treatment
use
cdna
synthesi
known
less
effici
dna
like
carri
right
sequenc
librari
prepar
abil
detect
dna
virus
use
rnatarget
method
also
doubt
influenc
specif
replic
cycl
given
viru
note
viral
metagenom
method
chosen
use
multipl
displac
amplif
therefor
like
bia
amplif
larger
genom
eg
bacteria
host
could
confound
result
consid
rel
abund
sequenc
metagenom
data
mani
differ
method
amplif
avail
repres
one
howev
amplif
method
one
practic
use
appli
viru
discoveri
studi
cheval
et
al
therefor
examin
enrich
techniqu
use
specif
amplif
method
still
relev
certainli
need
futur
studi
expand
work
full
valid
examin
effect
enrich
use
amplif
method
ie
sispa
nextera
lamp
lasl
would
also
interest
includ
greater
array
enrich
method
sampl
type
sequenc
platform
bioinformat
approach
may
includ
incorpor
sequenc
assembl
method
use
search
algorithm
find
present
provid
start
point
consid
use
rapid
simpl
enrich
method
purpos
diagnos
new
viral
diseas
human
anim
sampl
use
metagenom
studi
also
highlight
possibl
risk
arbitrarili
select
enrich
method
pure
base
upon
previous
publish
studi
rjh
mp
design
studi
assist
pec
qsh
provid
design
realtim
pcr
assay
akt
sy
hs
xr
nem
perform
experi
jw
ab
rjh
analys
data
rjh
mp
xr
nem
jw
pec
interpret
find
rjh
wrote
manuscript
draft
author
edit
manuscript
